$109B
$125 Million
0.06% of portfolio
512
Q3 2024
Added 2.2%
$0
$125 Million
0.06% of portfolio
3,583
Q1 2025
Reduced 15.34%
$0
$133 Million
0.06% of portfolio
1,357
Q1 2025
Reduced 29.73%
$47.1M
$124 Million
0.06% of portfolio
25,863
Q1 2024
Reduced 50.0%
$0
$117 Million
0.06% of portfolio
316
Q2 2023
New
$0
$132 Million
0.06% of portfolio
902
Q1 2025
Added 50.33%
$0
$130 Million
0.06% of portfolio
1,642
Q1 2025
Reduced 5.41%
$44.5B
$118 Million
0.06% of portfolio
902
Q1 2025
New
$0
$114 Million
0.06% of portfolio
971
Q1 2025
Reduced 1.32%
$15.1B
$121 Million
0.06% of portfolio
824
Q2 2023
New
$152B
$124 Million
0.06% of portfolio
3,368
Q1 2025
Reduced 8.0%
$0
$115 Million
0.06% of portfolio
1,407
Q2 2024
Reduced 36.25%
$37.9B
$117 Million
0.06% of portfolio
2,422
Q1 2025
Added 14.52%
$77.5B
$118 Million
0.06% of portfolio
434
Q4 2023
Added 40.45%
$55.4B
$123 Million
0.06% of portfolio
645
Q3 2024
Reduced 9.54%
$79.8B
$104 Million
0.05% of portfolio
75
Q2 2023
New
$68.2B
$112 Million
0.05% of portfolio
3,800
Q2 2023
New
$1.13B
$104 Million
0.05% of portfolio
5,000
Q1 2025
Reduced 50.0%
$53.2B
$95.8 Million
0.05% of portfolio
2,475
Q2 2023
New
$35.9B
$100 Million
0.05% of portfolio
907
Q2 2023
New
$41.6B
$101 Million
0.05% of portfolio
1,230
Q3 2024
Added 173.33%
$154B
$105 Million
0.05% of portfolio
1,475
Q3 2024
Reduced 7.23%
$0
$99.1 Million
0.05% of portfolio
236
Q1 2025
Reduced 12.59%
$46.5B
$109 Million
0.05% of portfolio
1,945
Q3 2024
Added 9.89%
$0
$109 Million
0.05% of portfolio
3,539
Q1 2025
Reduced 5.35%
$292B
$92.8 Million
0.05% of portfolio
1,293
Q1 2024
Reduced 7.84%
$14B
$110 Million
0.05% of portfolio
505
Q2 2023
New
$133B
$100 Million
0.05% of portfolio
368
Q2 2023
New
$0
$99.6 Million
0.05% of portfolio
583
Q2 2023
New
-
$94.3 Million
0.05% of portfolio
-
Q1 2025
Added 67.03%
$59.7B
$103 Million
0.05% of portfolio
422
Q1 2024
Reduced 8.66%
Glaxo Smithkline PLC Adr New
-
$102 Million
0.05% of portfolio
-
Q1 2025
Added 5.01%
$33.6B
$84.4 Million
0.04% of portfolio
1,130
Q1 2025
Reduced 3.67%
$81.1B
$75.8 Million
0.04% of portfolio
93
Q2 2023
New
$258B
$91.5 Million
0.04% of portfolio
1,249
Q3 2024
Reduced 12.6%
$266B
$85.4 Million
0.04% of portfolio
973
Q3 2024
Added 11.45%
$0
$85.4 Million
0.04% of portfolio
1,114
Q2 2023
New
$263B
$74.3 Million
0.04% of portfolio
277
Q1 2025
Added 78.71%
$0
$75.3 Million
0.04% of portfolio
293
Q4 2024
Added 19.11%
$0
$86.8 Million
0.04% of portfolio
1,479
Q1 2024
Added 136.64%
$0
$92 Million
0.04% of portfolio
620
Q3 2024
Reduced 26.45%
$0
$85.6 Million
0.04% of portfolio
256
Q4 2024
Added 34.74%
$73.2B
$82.9 Million
0.04% of portfolio
754
Q1 2025
Added 3.71%
$1.49B
$74.7 Million
0.04% of portfolio
1,488
Q1 2025
Added 86.0%
$48.4B
$90.2 Million
0.04% of portfolio
394
Q2 2023
New
$0
$82.7 Million
0.04% of portfolio
419
Q2 2023
New
$0
$86 Million
0.04% of portfolio
1,000
Q2 2024
Reduced 10.87%
$19.7B
$89.9 Million
0.04% of portfolio
3,070
Q4 2024
Reduced 7.28%
$76.6B
$81.2 Million
0.04% of portfolio
1,279
Q4 2024
Reduced 7.25%
$227B
$75.7 Million
0.04% of portfolio
649
Q3 2024
Added 30.06%